Cargando…
Identification and Structure-Activity Studies of 1,3-Dibenzyl-2-aryl imidazolidines as Novel Hsp90 Inhibitors
Hsp90 (Heat shock protein 90) is involved in various processes in cancer occurrence and development, and therefore represents a promising drug target for cancer therapy. In this work, a virtual screening strategy was employed, leading to the identification of a series of compounds bearing a scaffold...
Autores principales: | Liu, Yajun, Liu, Xiaoxia, Li, Lihong, Dai, Rui, Shi, Meiyun, Xue, Hongyu, Liu, Yong, Wang, Hecheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600241/ https://www.ncbi.nlm.nih.gov/pubmed/31163701 http://dx.doi.org/10.3390/molecules24112105 |
Ejemplares similares
-
1,3-Dibenzylimidazolidine-2-thione
por: Mietlarek-Kropidłowska, Anna, et al.
Publicado: (2012) -
2-(1,3-Dibenzylimidazolidin-2-ylidene)malononitrile
por: Feng, Xiao-Zhong, et al.
Publicado: (2008) -
1,3-Dibenzyl-2-(2-chlorophenyl)-4-methylimidazolidine
por: Rivera, Augusto, et al.
Publicado: (2012) -
Design, synthesis, biological evaluation and molecular docking study of 2,4-diarylimidazoles and 2,4-bis(benzyloxy)-5-arylpyrimidines as novel HSP90 N-terminal inhibitors
por: Yang, Man, et al.
Publicado: (2022) -
Thermodynamics of Aryl-Dihydroxyphenyl-Thiadiazole Binding to Human Hsp90
por: Kazlauskas, Egidijus, et al.
Publicado: (2012)